SCHEMBL7677919

SCHEMBL7677919

c1cc(CNCCCN2CCOCC2)cc(N2CCOCC2)n1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 2/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2D6 P10635 1/20 0.67
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
PARP1 P09874 1/20 0.46
ALDH1A1 P00352 2/20 0.44
PIK3CA P42336 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
POLB P06746 1/20 0.43
MAPK14 Q16539 1/20 0.42
GAA P10253 1/20 0.42
SLC40A1 Q9NP59 1/20 0.42
PIK3CB P42338 1/20 0.41
KDM1A O60341 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7682114 0.95 CYP2C19 (0.60) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7681152 0.93 CYP2D6 (0.55) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7679598 0.85 CYP3A4 (0.58) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL7679073 0.83 CYP3A4 (0.45) CYP2C19CYP3A4CYP2D6PIK3CAMAPK14
SCHEMBL3175221 0.78 CYP2C19 (0.80) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL10154083 0.78 PIK3CA (0.50) CYP2C19CYP3A4ALDH1A1PIK3CAPIK3CB
SCHEMBL10210050 0.78 PIK3CA (0.50) PIK3CAPIK3CB
SCHEMBL3179723 0.76 CYP2C19 (0.76) CYP2C19CYP3A4CYP2D6MEN1KMT2A
SCHEMBL24455071 0.75 RAB9A (0.53) CYP2C19ALDH1A1PIK3CASMN1; SMN2NPSR1
SCHEMBL29561895 0.75 RAB9A (0.53) CYP2C19ALDH1A1PIK3CASMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455520-B1 TUMOR NECROSIS FACTOR AND INTERLEUKIN INHIBITORS; ANTIINFLAMMATORY AGENTS, ANTIALLERGENS; BONE DISORDERS ASTRA ZENECA AB (SE) 2002-09-24 US disclosed